{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:13938"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:13938","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Determining the role of inhibitory antibodies on complement-mediated killing of \\(\\textit{Neisseria gonorrhoeae}\\) during acute gonorrhoea infection","abstract":"The mechanism of inhibitory antibodies produced by patients during acute gonorrhoea infection is largely unknown, and thus far there has been a lack of large-scale studies of the human immune response to the gonococcus to elucidate this mechanism. During this study, 336 clinical \\(\\textit{Neisseria gonorrhoeae}\\) isolates were screened for resistance against their autologous participant serum. Serum bactericidal assays revealed serum samples from nine participants which contained inhibitory antibodies. These isolates were sensitive to healthy serum, but resistant when incubated with the autologous participant serum. Antibody isotypes IgG, IgM and IgA were purified from inhibitory serum. After serum bactericidal assays with the autologous purified antibodies, it was observed that all isolates tested were protected from killing by healthy serum by purified inhibitory IgG and IgM at the highest concentrations trialled. IgA was able to inhibit killing in half of the isolates trialled. Closer analysis of the IgG subclasses involved in inhibition, showed a correlation between increased binding of IgG2 and a decreased binding of IgG3 to isolates demonstrating the inhibitory phenotype. This mechanism is distinct from previous literature on inhibitory antibodies against other Gram-negative organisms. Further analysis of the mechanism would be invaluable for informing gonococcal vaccine development.","abstract_html":"The mechanism of inhibitory antibodies produced by patients during acute gonorrhoea infection is largely unknown, and thus far there has been a lack of large-scale studies of the human immune response to the gonococcus to elucidate this mechanism. During this study, 336 clinical <span class=\"etd-inline-math\"><em>Neisseria gonorrhoeae</em></span> isolates were screened for resistance against their autologous participant serum. Serum bactericidal assays revealed serum samples from nine participants which contained inhibitory antibodies. These isolates were sensitive to healthy serum, but resistant when incubated with the autologous participant serum. Antibody isotypes IgG, IgM and IgA were purified from inhibitory serum. After serum bactericidal assays with the autologous purified antibodies, it was observed that all isolates tested were protected from killing by healthy serum by purified inhibitory IgG and IgM at the highest concentrations trialled. IgA was able to inhibit killing in half of the isolates trialled. Closer analysis of the IgG subclasses involved in inhibition, showed a correlation between increased binding of IgG2 and a decreased binding of IgG3 to isolates demonstrating the inhibitory phenotype. This mechanism is distinct from previous literature on inhibitory antibodies against other Gram-negative organisms. Further analysis of the mechanism would be invaluable for informing gonococcal vaccine development.","abstract_has_math":true,"creators":["McKeand, Samantha Anastasia"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-07","date_published":"2023-07","updated_at":"2026-11-19T09:32:26Z","subjects":["QR Microbiology","QR180 Immunology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000155797422"],"render_values":[{"text":"0000-0001-5579-7422","href":"https://orcid.org/0000-0001-5579-7422","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/13938/1/McKeand2023PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A13938","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["wellcome_trust"]},{"key":"dc:creator","label":"Author","values":["McKeand, Samantha Anastasia"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000155797422"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-07"]},{"key":"dc:date.issued","label":"Date","values":["2023-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Microbiology and Infection"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/13938/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology","QR180 Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/13938/1/McKeand2023PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The mechanism of inhibitory antibodies produced by patients during acute gonorrhoea infection is largely unknown, and thus far there has been a lack of large-scale studies of the human immune response to the gonococcus to elucidate this mechanism. During this study, 336 clinical \\(\\textit{Neisseria gonorrhoeae}\\) isolates were screened for resistance against their autologous participant serum. Serum bactericidal assays revealed serum samples from nine participants which contained inhibitory antibodies. These isolates were sensitive to healthy serum, but resistant when incubated with the autologous participant serum. Antibody isotypes IgG, IgM and IgA were purified from inhibitory serum. After serum bactericidal assays with the autologous purified antibodies, it was observed that all isolates tested were protected from killing by healthy serum by purified inhibitory IgG and IgM at the highest concentrations trialled. IgA was able to inhibit killing in half of the isolates trialled. Closer analysis of the IgG subclasses involved in inhibition, showed a correlation between increased binding of IgG2 and a decreased binding of IgG3 to isolates demonstrating the inhibitory phenotype. This mechanism is distinct from previous literature on inhibitory antibodies against other Gram-negative organisms. Further analysis of the mechanism would be invaluable for informing gonococcal vaccine development."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Determining the role of inhibitory antibodies on complement-mediated killing of \\(\\textit{Neisseria gonorrhoeae}\\) during acute gonorrhoea infection"]}]}],"canonical_facts":{"dc:contributor.sponsor":["wellcome_trust"],"dc:creator":["McKeand, Samantha Anastasia"],"dc:date":["2023-07"],"dc:date.issued":["2023-07"],"dc:description.abstract":["The mechanism of inhibitory antibodies produced by patients during acute gonorrhoea infection is largely unknown, and thus far there has been a lack of large-scale studies of the human immune response to the gonococcus to elucidate this mechanism. During this study, 336 clinical \\(\\textit{Neisseria gonorrhoeae}\\) isolates were screened for resistance against their autologous participant serum. Serum bactericidal assays revealed serum samples from nine participants which contained inhibitory antibodies. These isolates were sensitive to healthy serum, but resistant when incubated with the autologous participant serum. Antibody isotypes IgG, IgM and IgA were purified from inhibitory serum. After serum bactericidal assays with the autologous purified antibodies, it was observed that all isolates tested were protected from killing by healthy serum by purified inhibitory IgG and IgM at the highest concentrations trialled. IgA was able to inhibit killing in half of the isolates trialled. Closer analysis of the IgG subclasses involved in inhibition, showed a correlation between increased binding of IgG2 and a decreased binding of IgG3 to isolates demonstrating the inhibitory phenotype. This mechanism is distinct from previous literature on inhibitory antibodies against other Gram-negative organisms. Further analysis of the mechanism would be invaluable for informing gonococcal vaccine development."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/13938/1/McKeand2023PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Microbiology and Infection"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/13938/"],"dc:subject":["QR Microbiology","QR180 Immunology"],"dcterms:accessrights":["public"],"dc:title":["Determining the role of inhibitory antibodies on complement-mediated killing of \\(\\textit{Neisseria gonorrhoeae}\\) during acute gonorrhoea infection"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000155797422"]},"updated_at":"2026-11-19T09:32:26Z"}